Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B

Bone Marrow Transplantation

Volumn 22, Issue SUPPL. 4, 1998, Pages

  Kruger W H ^a   Kroger N ^a   Russmann B ^a   Renges, H ^a   Kabisch, H ^a   Zander, A R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Bone marrow transplantation; Fungi; Infections; Liposomal amphotericin B; Stem cell support

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; BILIRUBIN; CREATININE; LIPOSOME;

ABDOMINAL PAIN; ACUTE LEUKEMIA; ADOLESCENT; ADULT; APLASTIC ANEMIA; CANDIDA; CHILD; CHILL; CHRONIC LEUKEMIA; CONFERENCE PAPER; DRUG EFFICACY; DRUG TOXICITY; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYCOSIS; PRIORITY JOURNAL; SEPTICEMIA; SIDE EFFECT; VOMITING;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIA; MALE; MIDDLE AGED; MYCOSES;

EID: 0032406514     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Krüger W, Sobottka I, Stockschläder M, Mross K, Hoffknecht M, Rüssmann B, Horstmann M, Betker R, Zander A. Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values. Scand.J.Infect.Dis. 1996;28(3):313-6.
2. Nosari A, Barberis M, Landonio G, Magnani P, Majno M, Oreste P, Sozzi P. Infections in haematologic neoplasms: autopsy findings. Haematologica 1991;76(2):135-40.
3. Wade JC. Principles of empiric antibiotic usage in febrile patients with granulocytopenia. J.Antimicrob.Chemother. 1982;9 Suppl A:215-22:215-22.
4. Meyers JD. Fungal infections in bone marrow transplant patients. Semin.Oncol. 1990;17(3 Suppl 6):10-3.
5. Warnock DW. Amphotericin B: an introduction. J.Antimicrob.Chemother. 1991;28Suppl B:27-38:27-38.
6. Prentice HG, Gluckman E, Powles RL, Ljungman P, Milpied N, Fernandez RJ, Mandelli F, Kho P, Kennedy L, Bell AR. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet 1994;343(8900):749-53.
7. Adler-Moore J. AmBisome targeting to fungal infections. Bone Marrow Transplant. 1994;14 Suppl 5:S3-7:S3-S7 .
8. Ringden O, Tollemar J. Liposomal amphotericin B (AmBisome) treatment of invasive fungal infections in immunocompromised children. Mycoses. 1993;36(5-6):187-92.
9. Meyer RD. Current role of therapy with amphotericin B. Clin.Infect.Dis. 1992;14 Suppl 1:S154-60:S154-S160
10. Mills W, Chopra R, Linch DC, Goldstone AH. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. Br.J.Haematol. 1994;86(4):754-60.